Clinical Trials Logo
  1. Home
  2. Tobacco Abuse Cigarette
  3. NCT01575145
  4. Details
NCT01575145 Clinical Trial

Helping Hospitalized Patients Quit Smoking

Tobacco Abuse Cigarette Clinical Trial

Official title:
Helping Hospitalized Patients Quit Smoking

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01575145
Other study ID # 12-002207
Secondary ID
Status Completed
Phase Phase 4
First received April 9, 2012
Last updated January 8, 2016
Start date May 2012
Est. completion date November 2015

Study information
Verified date January 2016
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The study is being done to determine whether an in-hospital intervention using a brief intervention to facilitate quitline utilization will increase quitline utilization by hospitalized smokers, and will increase post hospital discharge smoking abstinence rates.

Study participants will be randomized to receive either a brief quitline facilitation intervention , or a control intervention of a brief stop-smoking message.

The study will also compare healthcare costs and utilization in the first six months following hospitalization between the two groups.

Recruitment information / eligibility
Status Completed
Enrollment 600
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

Current smoker, Resident of Olmsted County, Inpatient admission to St. Marys or Rochester Methodist Hospital, Able to participate fully in all study aspects, Available for follow-up

Exclusion Criteria:

Current active treatment for tobacco use initiated prior to hospitalization

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Behavioral:
• Quitline facilitation intervention
brief quitline facilitation intervention
• Brief stop-smoking intervention
brief review of tips to help maintain smoking abstinence, using brochure

Locations
Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)
Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary 7-day point prevalence tobacco abstinence at 6 months after hospitalization 6 months after hospitalization No
Secondary Self-efficacy Use of Smoking Self-Efficacy Questionnaire 12 Immediately after the delivery of the brief intervention (day of enrollment) No